Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gamal Shiha

Showing results (11-20 of 77) with videos related to

Pageof 8
Sort By:
Hepatology International|January 16, 2022
Predictive performance and clinical utility of HCC risk scores in chronic hepatitis C: a comparative studyGamal Shiha, Nabiel N H Mikhail, Reham Soliman, et al.
Inflammation and Regeneration|December 21, 2017
Effect of human umbilical cord blood stem cell transplantation on oval cell response in 2-AAF/CCL4 liver injury model: experimental immunohistochemical studyHussein Abdellatif, Gamal Shiha, Dalia M Saleh, et al.
Scientific Reports|February 26, 2021
Novel combined single dose anti-hepatitis C therapy: a pilot studyGamal Shiha, Reham Soliman, Mohamed Elbasiony, et al.
Computational and Structural Biotechnology Journal|June 21, 2021
Temperature responsive smart polymer for enabling affinity enrichment of current coronavirus (SARS-CoV-2) to improve its diagnostic sensitivityAhmed Nabil, Erika Yoshihara, Keita Hironaka, et al.
Scientific Reports|September 21, 2019
Addition of Epigallocatechin Gallate 400 mg to Sofosbuvir 400 mg + Daclatisvir 60 mg With or Without Ribavirin in Treatment of Patients with Chronic Hepatitis C Improves the Safety Profile: A Pilot StudyGamal Shiha, Reham Soliman, Mohamed Elbasiony, et al.
Journal of Viral Hepatitis|January 31, 2020
A same day 'test and treat' model for chronic HCV and HBV infection: Results from two community-based pilot studies in EgyptGamal Shiha, Reham Soliman, Abdalhamed Serwah, et al.
Journal of Viral Hepatitis|February 13, 2020
Incidence of HCC in chronic hepatitis C patients with advanced hepatic fibrosis who achieved SVR following DAAs: A prospective studyGamal Shiha, Nasser Mousa, Reham Soliman, et al.
Journal of Viral Hepatitis|September 28, 2021
Seroprevalence and epidemiological characteristics of HDV infection among HBV patients in the Nile Delta, EgyptWafaa Elzefzafy, Reham Soliman, Layla Saleh, et al.
The Lancet. Gastroenterology & Hepatology|July 22, 2018
An educate, test, and treat programme towards elimination of hepatitis C infection in Egypt: a community-based demonstration projectGamal Shiha, Ammal M Metwally, Reham Soliman, et al.
The Journal of the Royal College of Physicians of Edinburgh|June 16, 2021
UK internal medicine training in the time of COVID-19Sana Sharrack, Caroline Ann Zollinger-Read, Miriam Faith Cox, et al.
Pageof 8

Showing results (11-20 of 77) with videos related to

Sort By:
Pageof 8
Hepatology International|January 16, 2022
Predictive performance and clinical utility of HCC risk scores in chronic hepatitis C: a comparative studyGamal Shiha, Nabiel N H Mikhail, Reham Soliman, et al.
Inflammation and Regeneration|December 21, 2017
Effect of human umbilical cord blood stem cell transplantation on oval cell response in 2-AAF/CCL4 liver injury model: experimental immunohistochemical studyHussein Abdellatif, Gamal Shiha, Dalia M Saleh, et al.
Scientific Reports|February 26, 2021
Novel combined single dose anti-hepatitis C therapy: a pilot studyGamal Shiha, Reham Soliman, Mohamed Elbasiony, et al.
Computational and Structural Biotechnology Journal|June 21, 2021
Temperature responsive smart polymer for enabling affinity enrichment of current coronavirus (SARS-CoV-2) to improve its diagnostic sensitivityAhmed Nabil, Erika Yoshihara, Keita Hironaka, et al.
Scientific Reports|September 21, 2019
Addition of Epigallocatechin Gallate 400 mg to Sofosbuvir 400 mg + Daclatisvir 60 mg With or Without Ribavirin in Treatment of Patients with Chronic Hepatitis C Improves the Safety Profile: A Pilot StudyGamal Shiha, Reham Soliman, Mohamed Elbasiony, et al.
Journal of Viral Hepatitis|January 31, 2020
A same day 'test and treat' model for chronic HCV and HBV infection: Results from two community-based pilot studies in EgyptGamal Shiha, Reham Soliman, Abdalhamed Serwah, et al.
Journal of Viral Hepatitis|February 13, 2020
Incidence of HCC in chronic hepatitis C patients with advanced hepatic fibrosis who achieved SVR following DAAs: A prospective studyGamal Shiha, Nasser Mousa, Reham Soliman, et al.
Journal of Viral Hepatitis|September 28, 2021
Seroprevalence and epidemiological characteristics of HDV infection among HBV patients in the Nile Delta, EgyptWafaa Elzefzafy, Reham Soliman, Layla Saleh, et al.
The Lancet. Gastroenterology & Hepatology|July 22, 2018
An educate, test, and treat programme towards elimination of hepatitis C infection in Egypt: a community-based demonstration projectGamal Shiha, Ammal M Metwally, Reham Soliman, et al.
The Journal of the Royal College of Physicians of Edinburgh|June 16, 2021
UK internal medicine training in the time of COVID-19Sana Sharrack, Caroline Ann Zollinger-Read, Miriam Faith Cox, et al.
Pageof 8